Vical to Present at the 27th Annual ROTH Conference
March 05 2015 - 6:00AM
Vical Incorporated (Nasdaq:VICL) today announced that the company
will provide an overview of its technologies, development programs,
and outlook on Wednesday, March 11, at 11:30 a.m. PDT at the ROTH
Capital Partners 27th Annual ROTH Conference (Newport Beach,
California March 8 – 11). A webcast of the company's presentation
will be available live and archived through the Events &
Presentations page in the Investors section of the Vical website at
www.vical.com.
About Vical
Vical researches and develops biopharmaceutical products
leveraging its patented DNA delivery technologies for the
prevention and treatment of chronic or life-threatening infectious
diseases. In addition, the company has collaborations with major
pharmaceutical and biotechnology companies focused on addressing
significant unmet medical needs. Additional information on Vical is
available at www.vical.com.
CONTACT: Andrew Hopkins
(858) 646-1127
Website: www.vical.com
Vical (NASDAQ:VICL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vical (NASDAQ:VICL)
Historical Stock Chart
From Apr 2023 to Apr 2024